Cell therapy manufacturer and hospital network with GMP compliance focus
Amerikan Hastanesi operates as a dual-entity: a historic hospital network serving Turkey and surrounding regions, plus an emerging cell therapy manufacturing operation. The project and pain-point lists reveal heavy emphasis on exosome production, process validation, and cGMP compliance—suggesting a biotech manufacturing arm alongside clinical care. Hiring velocity is accelerating across manufacturing (largest cohort) and healthcare, with mid-level roles dominating, pointing toward scaled production ramp rather than leadership consolidation.
Notable leadership hires: IT Operations Lead
Founded in 1920 as Turkey's first non-profit private hospital, Amerikan Hastanesi is now a 1,001–5,000-person operation headquartered in İstanbul's Şişli district. The organization serves patients across Turkey and neighboring countries with hospital-based care and, more recently, cell therapy manufacturing. Active projects span exosome production processes, process validation, cGMP compliance infrastructure, financial reporting, and quality control systems. The organization operates on a Linux and Windows infrastructure with Oracle databases and Microsoft 365 enterprise tools; Power BI and LIMS systems support operational analytics and lab workflows.
Oracle databases, Microsoft 365, Power BI for analytics, LIMS for lab management, qPCR instrumentation, Active Directory, and both Linux and Windows infrastructure.
Exosome production and cell therapy manufacturing, process validation, cGMP compliance infrastructure, quality control systems, in-process controls, SOP development, and patient financial process improvement.
Other companies in the same industry, closest in size